Microcirculation and atherothrombotic parameters in prolactinoma patients: A pilot study

Pituitary

Volumn 15, Issue 4, 2012, Pages 472-481

  Reuwer, Anne Q ^a   Sondermeijer, Brigitte M ^a   Battjes, Suzanne ^a   Van Zijderveld, Rogier ^b   Stuijver, Danka J F ^a,c   Bisschop, Peter H ^a   Twickler, Marcel Th B ^d   Meijers, Joost C M ^a   Schlingemann, Reinier O ^a   Stroes, Erik S ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Atherothrombosis; Coagulation; Inflammation; Microcirculation; Prolactinoma

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROLACTIN; PROTHROMBIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD CLOTTING PARAMETERS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMODYNAMIC PARAMETERS; HIGH RISK PATIENT; HUMAN; INSULIN BLOOD LEVEL; MALE; MICROANGIOPATHY; MICROCIRCULATION; MICROVASCULAR FLOW INDEX; MOLECULAR PATHOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; PROTEIN BLOOD LEVEL; RETINA FLUORESCEIN ANGIOGRAPHY; RISK ASSESSMENT; THROMBIN POTENTIAL; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PROLACTINOMA; PROTHROMBIN; THROMBIN;

EID: 84870315775     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-011-0353-9     Document Type: Article

References (48)

1. Lusis AJ (2000) Atherosclerosis. Nature 407: 233-241
2. Lee KW, Lip GY (2003) Acute coronary syndromes: Virchow's triad revisited. Blood Coagul Fibrinolysis 14: 605-625
3. van Zaane B, Reuwer A, Büller H, Kastelein J, Gerdes V, Twickler M (2009) Hormones and cardiovascular disease: a shift in paradigm with clinical consequences? Semin Thromb Hemost 35: 478-487
4. Ben-Jonathan N, LaPensee CR, LaPensee EW (2008) What can we learn from rodents about prolactin in humans? Endocr Rev 29: 1-41
5. Reuwer AQ, van Eijk M, Houttuijn-Bloemendaal FM, van der Loos CM, Claessen N, Teeling P, Kastelein JJP, Hamann J, Goffin V, von der Thusen JH, Twickler M, Aten J (2011) The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? J Endocrinol 208: 107-117
6. Chavez-Rueda K, Hérnandéz J, Zenteno E, Leaños-Miranda A, Legorreta-Haquet MV, Blanco-Favela F (2005) Identification of prolactin as a novel immunomodulator on the expression of costimulatory molecules and cytokine secretions on T and B human lymphocytes. Clin Immunol 116: 182-191
7. Montes de Oca P, Macotela Y, Nava G, Lopez-Barrera F, de la Escalera GM, Clapp C (2005) Prolactin stimulates integrinmediated adhesion of circulating mononuclear cells to endothelial cells. Lab Invest 85: 633-642
8. Levi M, van der Poll T, Buller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109: 2698-2704
9. Grosdemouge I, Bachelot A, Lucas A, Baran N, Kelly P, Binart N (2003) Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod Biol Endocrinol 1: 12
10. Ko JY, Ahn YL, Cho BN (2003) Angiogenesis and white blood cell proliferation induced in mice by injection of a prolactinexpressing plasmid into muscle. Mol Cells 15: 262-267
11. Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner RI, Martial JA (1999) Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 96: 1246-1251
12. Molinari C, Grossini E, Mary DASG, Uberti F, Ghigo E, Ribichini F, Surico N, Vacca G (2007) Prolactin induces regional vasoconstriction through the {beta}2-adrenergic and nitric oxide mechanisms. Endocrinology 148: 4080-4090
13. Le Moli R, Endert E, Fliers E, Mulder T, Prummel MF, Romijn JA, Wiersinga WM (1999) Establishment of reference values for endocrine tests II: hyperprolactinemia. Neth J Med 55: 71-75
14. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Béguin S (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33: 4-15
15. Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi M, Bajaj J, Abate NL, Arnold RC, Colilla S, Zanotti S, Hollenberg SM (2007) Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 49: 88-98
16. De Backer D, Hollenberg S, Boerma C, Goedhart P, Büchele G, Ospina-Tascon G, Dobbe I, Ince C (2007) How to evaluate the microcirculation: report of a round table conference. Crit Care 11:R101
17. Klyscz T, Jünger M, Jung F, Zeintl H (1997) Cap image-a new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech (Berl) 42: 168-175
18. Spronk PE, Ince C, Gardien MJ, Mathura KR, Straaten HMO, Zandstra DF (2002) Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360: 1395-1396
19. Hemker HC, Béguin S (1995) Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 74: 134-138
20. Hemker HC, Al Dieri R, De Smedt E, Béguin S (2006) Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96: 553-561
21. Nishino Y (1979) Hormonal control of prothrombin synthesis in rat liver microsomes, with special reference to the role of estradiol, testosterone and prolactin. Arch Toxicol Suppl 2: 397-402
22. Karmali RA, Horrobin DF (1975) Letter: prolactin, bromocriptine, and haemostasis. Br Med J 3: 307
23. Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O (2010) Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma. Clin Endocrinol 73: 502-507
24. Dorshkind K, Horseman ND (2000) The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency. Endocr Rev 21: 292-312
25. Schuett H, Luchtefeld M, Grothusen C, Grote K, Schieffer B (2009) How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost 102: 215-222
26. Nishida H, Horio T, Suzuki Y, Iwashima Y, Tokudome T, Yoshihara F, Nakamura S, Kawano Y (2011) Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein. Cytokine 53: 342-346
27. Friedrich N, Schneider HJ, Spielhagen C, Markus MRP, Haring R, Grabe HJ, Buchfelder M, Wallaschofski H, Nauck M (2011) The association of serum prolactin concentration with inflammatory biomarkers - cross-sectional findings from the population- based Study of Health in Pomerania. Clinical Endocrinology 2011 (Epub ahead of print)
28. Zellweger R, Zhu XH, Wichmann MW, Ayala A, De Maso CM, Chaudry IH (1996) Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol 157: 5748-5754
29. Serri O, Li L, Mamputu JC, Beauchamp MC, Maingrette F, Renier G (2006) The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol 64: 366-370
30. Yavuz D, Deyneli O, Akpinar I, Yildiz E, Gozu H, Sezgin O, Haklar G, Akalin S (2003) Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic premenopausal women. Eur J Endocrinol 149: 187-193
31. Heshmati HM, Turpin G, de Gennes JL (1987) Chronic hyperprolactinemia and plasma lipids in women. Klin Wochenschr 65: 516-519
32. Pelkonen R, Nikkilä EA, Grahne B (1982) Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. Clin Endocrinol (Oxf) 16: 383-390
33. Berinder K, Nyström T, Höybye C, Hall K, Hulting AL (2010) Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Pituitary 3: 199-207
34. Haas MJ, Mooradian AD (2010) Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease. Diabetes Metab Res Rev 26: 90-99
35. Hermsdorff H, Zulet M, Puchau B, Martínez JA (2011) Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 34: 161-170
36. Reaven PD, Emanuele N, Moritz T, Klein R, Davis M, Glander K, Duckworth W, Abraira C (2008) Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the veterans affairs diabetes trial (VADT). Diabetes Care 31: 952-957
37. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, Wofford MR, Sharrett AR (2001) Retinal microvascular abnormalities and incident stroke: the atherosclerosis risk in communities study. Lancet 358: 1134-1140
38. Savage HI, Hendrix JW, Peterson DC, Young H, Wilkinson CP (2004) Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy. Invest Ophthalmol Vis Sci 45: 4504-4509
39. Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, Lykka M, Kyrkou K, Rizos D, Creatsa M, Christodoulakos G, Alevizaki M, Sfikakis PP, Papamichael C (2009) Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 54: 98-105
40. Ricken AM, Traenkner A, Merkwitz C, Hummitzsch K, Grosche J, Spanel-Borowski K (2007) The short prolactin receptor predominates in endothelial cells of micro- and macrovascular origin. J Vasc Res 44: 19-30
41. Sauro MD, Zorn NE (1991) Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C-dependent mechanism. J Cell Physiol 148: 133-138
42. Hirano K, Hirano M, Kanaide H (2004) Regulation of myosin phosphorylation and myofilament Ca2 ? sensitivity in vascular smooth muscle. J Smooth Muscle Res 40: 219-236
43. Segal SS (2005) Regulation of blood flow in the microcirculation. Microcirculation 12: 33-45
44. Delaey C, Van de Voorde J (2000) Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res 32: 249-256
45. Patton N, Aslam T, MacGillivray T, Pattie A, Deary IJ, Dhillon B (2005) Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 206: 319-348
46. Bosch MM, Merz TM, Barthelmes D, Petrig BL, Truffer F, Bloch KE, Turk A, Maggiorini M, Hess T, Schoch OD, Hefti U, Sutter FK, Pichler J, Huber A, LandauK(2009) Newinsights into ocular blood flow at very high altitudes. J Appl Physiol 106: 454-460
47. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR (2005) Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 65: 1005-1009
48. Colao A, Sarno AD, Cappabianca P, Briganti F, Pivonello R, Somma CD, Faggiano A, Biondi B, Lombardi G (2003) Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol 148: 325-331